TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Magnesium Sulfate Versus Nifedipine for the Acute Tocolysis of Preterm Labor: A Prospective, Randomized Trial
Brief Summary: To compare intravenous magnesium sulfate to oral nifedipine for acute tocolysis of preterm labor


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Indomethacin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Indomethacin | Intervention Type: DRUG; Name: Indomethacin; Assigned to Arm(s): Indomethacin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Magnesium Sulfate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Magnesium Sulfate | Arm Label: Nifedipine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nifedipine | Intervention Type: DRUG; Name: Magnesium Sulfate; Assigned to Arm(s): Magnesium Sulfate | Intervention Type: DRUG; Name: Nifedipine; Assigned to Arm(s): Nifedipine
C: Arm Label: Group one have received Transdermal nitroglycerin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Transdermal nitroglycerin | Arm Label: Group two have received nifedipine; Type: ACTIVE_COMPARATOR; Interventions: Drug: nifedipine | Intervention Type: DRUG; Name: Transdermal nitroglycerin; Assigned to Arm(s): Group one have received Transdermal nitroglycerin | Intervention Type: DRUG; Name: nifedipine; Assigned to Arm(s): Group two have received nifedipine
D: Arm Label: Nifedipine; Type: EXPERIMENTAL; Interventions: Drug: Nifedipine | Arm Label: Indomethacin; Type: EXPERIMENTAL; Interventions: Drug: Indomethacin | Intervention Type: DRUG; Name: Nifedipine; Assigned to Arm(s): Nifedipine | Intervention Type: DRUG; Name: Indomethacin; Assigned to Arm(s): Indomethacin

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Nifedipine for the Maintenance Tocolysis of Preterm Labor: Comparison to Placebo in a Prospective, Randomized Double Blind Trial
Brief Summary: Comparing nifedipine to placebo for the maintenance tocolysis of preterm labor


Options:
A: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Nifedipine extended release | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Nifedipine extended release; Assigned to Arm(s): A
B: Arm Label: Active; Type: EXPERIMENTAL; Interventions: Drug: OBE022, Drug: Atosiban | Arm Label: Placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: Placebos, Drug: Atosiban | Intervention Type: DRUG; Name: OBE022; Assigned to Arm(s): Active | Intervention Type: DRUG; Name: Placebos; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Atosiban; Assigned to Arm(s): Active, Placebo
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Atosiban | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Nifedipine | Intervention Type: DRUG; Name: Atosiban; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Nifedipine; Assigned to Arm(s): 2
D: Arm Label: Nifedipine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nifedipine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Nifedipine | Intervention Type: DRUG; Name: Nifedipine; Assigned to Arm(s): Nifedipine, Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized, Double Blind Trial of Magnesium Sulfate Tocolysis Versus Intravenous Saline for Suspected Placental Abruption
Brief Summary: To evaluate the safety and efficacy of magnesium sulfate for preterm suspected abruption.


Options:
A: Arm Label: Nifedipine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nifedipine 20 Mg | Arm Label: Ritodrine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ritodrine Oral Tablet | Intervention Type: DRUG; Name: Nifedipine 20 Mg; Assigned to Arm(s): Nifedipine | Intervention Type: DRUG; Name: Ritodrine Oral Tablet; Assigned to Arm(s): Ritodrine
B: Intervention Type: DRUG; Name: Indomethacin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Magnesium sulfate; Assigned to Arm(s): N/A
C: Arm Label: Magnesium Sulfate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Magnesium Sulfate | Arm Label: Normal Saline; Type: PLACEBO_COMPARATOR; Interventions: Other: Normal Saline | Intervention Type: DRUG; Name: Magnesium Sulfate; Assigned to Arm(s): Magnesium Sulfate | Intervention Type: OTHER; Name: Normal Saline; Assigned to Arm(s): Normal Saline
D: Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: indomethacin; Type: EXPERIMENTAL; Interventions: Drug: indomethacin | Intervention Type: DRUG; Name: indomethacin; Assigned to Arm(s): indomethacin | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Sports to Prevent Obesity: Feasibility and Pilot RCT
Brief Summary: The purpose of this study is to learn whether overweight children who participate in an after school sports program improve their health as much as overweight children in a more traditional health education program.


Options:
A: Intervention Type: BEHAVIORAL; Name: exercise; Assigned to Arm(s): N/A
B: Arm Label: After school sports; Type: EXPERIMENTAL; Interventions: Behavioral: After school sports program | Arm Label: After school health education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: After school health education | Intervention Type: BEHAVIORAL; Name: After school sports program; Assigned to Arm(s): After school sports | Intervention Type: BEHAVIORAL; Name: After school health education; Assigned to Arm(s): After school health education
C: Arm Label: Intervention; Type: OTHER; Interventions: Behavioral: Healthy Eating and Physical Activity | Intervention Type: BEHAVIORAL; Name: Healthy Eating and Physical Activity; Assigned to Arm(s): Intervention
D: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Active play in after school programs (ASP) | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Active play in after school programs (ASP); Assigned to Arm(s): Intervention group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Sports to Prevent Obesity: Feasibility and Pilot RCT
Brief Summary: The purpose of this study is to learn whether overweight children who participate in an after school sports program improve their health as much as overweight children in a more traditional health education program.


Options:
A: Intervention Type: BEHAVIORAL; Name: Diet with increased fruits, vegetables, and calcium; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Increased high impact activity and resistance training; Assigned to Arm(s): N/A
B: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: School children and adolescents as health experts | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: School children and adolescents as health experts; Assigned to Arm(s): A
C: Arm Label: After school sports; Type: EXPERIMENTAL; Interventions: Behavioral: After school sports program | Arm Label: After school health education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: After school health education | Intervention Type: BEHAVIORAL; Name: After school sports program; Assigned to Arm(s): After school sports | Intervention Type: BEHAVIORAL; Name: After school health education; Assigned to Arm(s): After school health education
D: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Intervention group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Acupuncture and Massage for Depression During Pregnancy
Brief Summary: This study evaluates the efficacy of acupuncture and massage for the treatment of depression during pregnancy. The study also examines differential effects of study treatments on delivery outcome and post partum depression.


Options:
A: Arm Label: Active acupuncture group; Type: EXPERIMENTAL; Interventions: Procedure: Active acupuncture | Arm Label: Placebo acupuncture group; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Placebo acupuncture | Intervention Type: PROCEDURE; Name: Active acupuncture; Assigned to Arm(s): Active acupuncture group | Intervention Type: PROCEDURE; Name: Placebo acupuncture; Assigned to Arm(s): Placebo acupuncture group
B: Arm Label: EPA-rich fish oil supplement; Type: ACTIVE_COMPARATOR; Interventions: Drug: EPA-rich fish oil supplement | Arm Label: DHA-rich fish oil supplement; Type: ACTIVE_COMPARATOR; Interventions: Drug: DHA-rich fish oil supplement | Arm Label: Soy Oil placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: EPA-rich fish oil supplement; Assigned to Arm(s): EPA-rich fish oil supplement | Intervention Type: DRUG; Name: DHA-rich fish oil supplement; Assigned to Arm(s): DHA-rich fish oil supplement | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Soy Oil placebo
C: Intervention Type: PROCEDURE; Name: Acupuncture; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Perinatal massage; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Omega-3 fatty acids | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Omega-3 fatty acids | Intervention Type: DIETARY_SUPPLEMENT; Name: Omega-3 fatty acids; Assigned to Arm(s): 1, 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study (MACS)
Brief Summary: In women at 26 to 30 weeks gestation and who are risk for threatened early birth, who have not had their baby by 14 or more days after being given a single course of antenatal corticosteroids (ACS), do repeated courses of ACS every 14 days until 33 weeks' gestational age lower the risk of illness or death in babies compared to repeated courses of placebo. Children are assessed at 2 years and 5 years for neurodevelopmental impairment.


Options:
A: Intervention Type: DRUG; Name: Betamethasone; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Multiple vs. single courses of antenatalcorticosteroids; Assigned to Arm(s): N/A
C: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: betamethasone | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: betamethasone; Assigned to Arm(s): A | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): B
D: Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Increasing use of Antenatal Corticosteroids (ACS) | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Increasing use of Antenatal Corticosteroids (ACS); Assigned to Arm(s): Intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study (MACS)
Brief Summary: In women at 26 to 30 weeks gestation and who are risk for threatened early birth, who have not had their baby by 14 or more days after being given a single course of antenatal corticosteroids (ACS), do repeated courses of ACS every 14 days until 33 weeks' gestational age lower the risk of illness or death in babies compared to repeated courses of placebo. Children are assessed at 2 years and 5 years for neurodevelopmental impairment.


Options:
A: Intervention Type: DRUG; Name: Betamethasone; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Multiple vs. single courses of antenatalcorticosteroids; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: Betamethasone sodium phos (drug); Assigned to Arm(s): N/A
D: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: betamethasone | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: betamethasone; Assigned to Arm(s): A | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): B

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study (MACS)
Brief Summary: In women at 26 to 30 weeks gestation and who are risk for threatened early birth, who have not had their baby by 14 or more days after being given a single course of antenatal corticosteroids (ACS), do repeated courses of ACS every 14 days until 33 weeks' gestational age lower the risk of illness or death in babies compared to repeated courses of placebo. Children are assessed at 2 years and 5 years for neurodevelopmental impairment.


Options:
A: Intervention Type: DRUG; Name: Betamethasone; Assigned to Arm(s): N/A
B: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: betamethasone | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: betamethasone; Assigned to Arm(s): A | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): B
C: Intervention Type: DRUG; Name: Betamethasone sodium phos (drug); Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: Multiple vs. single courses of antenatalcorticosteroids; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Clinically-Important Venous Thromboembolism Following Lower Extremity Fractures: Epidemiology & Prevention
Brief Summary: It is known that patients who fracture their legs sometimes develop blood clots (known as deep vein thrombosis) in their legs. These clots may cause pain and swelling in the leg or they may detach and travel to the lungs producing shortness of breath, chest pain, and sometimes death. Unfortunately, it is not known how frequently these complications occur after leg fractures, or if the use of a blood thinner medication can effectively and safely prevent these clots. Doctors at hospitals across Canada are conducting a study in which patients who have surgery for leg fractures receive either a once-daily injection of a blood thinner, known as low molecular weight heparin, or a placebo injection for up to 14 days after their fractures. Neither the patients nor the doctors know which patient is on the medication and which patient is on placebo. All patients receive an ultrasound examination of their legs at 2 weeks after surgery to monitor for deep vein thrombosis. In addition, all patients are checked for symptoms of leg or lung clots and any side effects of the medication for 3 months. If the blood thinner is shown to be effective at reducing this complication and documented to be safe and cost-effective in this setting it will be recommended for use in such patients. If, on the other hand, the frequency of deep vein thrombosis is too low to justify the cost or inconvenience of taking this medication, this will also be an important finding.


Options:
A: Intervention Type: DRUG; Name: Low Molecular Weight Heparin (dalteparin); Assigned to Arm(s): N/A
B: Arm Label: LMWH; Type: EXPERIMENTAL; Interventions: Drug: LMWH | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: LMWH; Assigned to Arm(s): LMWH
C: Arm Label: LMWH; Type: EXPERIMENTAL; Interventions: Drug: LMWH | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: LMWH; Assigned to Arm(s): LMWH
D: Arm Label: LMWH (Fragmin, dalteparin); Type: ACTIVE_COMPARATOR; Interventions: Drug: LMWH (Fragmin, dalteparin) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Unfractionated Heparin | Intervention Type: DRUG; Name: LMWH (Fragmin, dalteparin); Assigned to Arm(s): LMWH (Fragmin, dalteparin) | Intervention Type: DRUG; Name: Unfractionated Heparin; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Enhanced Feedback for Effective Cardiac Treatment (EFFECT)
Brief Summary: Randomized cluster trial of cardiac report cards for AMI and CHF. 103 acute care Ontario hospitals/85 hospital corporations participating, randomized to two groups: Group A Early Feedback and Group B Delayed Feedback.

Two phases of retrospective chart review of AMI and CHF separations to assess the impact of the public release of hospital specific performance on a set of Canadian quality indicators.


Options:
A: Intervention Type: PROCEDURE; Name: Quality Initiative in Rectal Cancer (QIRC) strategy; Assigned to Arm(s): N/A
B: Arm Label: MD-C/PT-C; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: MD-I/PT-C; Type: EXPERIMENTAL; Interventions: Behavioral: MD CQI-type intervention | Arm Label: MD-C/Pt-I; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle interventions to lower blood pressure for patients | Arm Label: MD-I/Pt-I; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle interventions to lower blood pressure for patients, Behavioral: MD CQI-type intervention | Intervention Type: BEHAVIORAL; Name: Lifestyle interventions to lower blood pressure for patients; Assigned to Arm(s): MD-C/Pt-I, MD-I/Pt-I | Intervention Type: BEHAVIORAL; Name: MD CQI-type intervention; Assigned to Arm(s): MD-I/PT-C, MD-I/Pt-I
C: Arm Label: Early Feedback Arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Publicly released hospital cardiac report cards | Arm Label: Delayed Feedback Arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Publicly released hospital cardiac report cards | Intervention Type: BEHAVIORAL; Name: Publicly released hospital cardiac report cards; Assigned to Arm(s): Delayed Feedback Arm, Early Feedback Arm
D: Intervention Type: PROCEDURE; Name: meeting nurses / physicians, quality improvement sessions; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: This is a 52-week, multicenter, open label trial of memantine (Namenda) for frontotemporal lobar degeneration (FTLD). The goal is to determine the safety and tolerability of this FDA-approved medication for Alzheimer's Disease in patients with FTLD. Secondary outcome measures include cognitive batteries, rating scales for activities of daily living and neuropsychiatric symptoms. All patients receive the FDA-approved dose of this medication for Alzheimer's disease.


Options:
A: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: dl-alpha-tocopherol | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Drug: Memantine | Arm Label: Arm 3; Type: EXPERIMENTAL; Interventions: Drug: dl-alpha-tocopherol, Drug: Memantine | Arm Label: Arm 4; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: dl-alpha-tocopherol; Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: Memantine; Assigned to Arm(s): Arm 2 | Intervention Type: DRUG; Name: dl-alpha-tocopherol; Assigned to Arm(s): Arm 3 | Intervention Type: DRUG; Name: Memantine; Assigned to Arm(s): Arm 3 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Arm 4
B: Arm Label: Memantine; Type: EXPERIMENTAL; Interventions: Drug: Memantine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Memantine; Assigned to Arm(s): Memantine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Intervention Type: DRUG; Name: Memantine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: Memantine; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Two Strategies for Setting Positive End-Expiratory Pressure in Acute Lung Injury/ Acute Respiratory Distress Syndrome (ExPress Study).
Brief Summary: The aim of this multicenter randomized controlled trial is to compare the impact on mortality of patients mechanically ventilated for acute lung injury or acute respiratory distress syndrome of two strategies for setting end-expiratory pressure.


Options:
A: Arm Label: HFO-TGI; Type: EXPERIMENTAL; Interventions: Other: High Frequency Oscillation and Tracheal Gas Insufflation | Arm Label: CMV; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: High Frequency Oscillation and Tracheal Gas Insufflation; Assigned to Arm(s): HFO-TGI
B: Arm Label: A; Type: EXPERIMENTAL; Interventions: Procedure: prone position | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: prone position; Assigned to Arm(s): A
C: Arm Label: Minimal alveolar distension; Type: ACTIVE_COMPARATOR; Interventions: Device: Setting of positive end-expiratory pressure | Arm Label: Maximal alveolar distension; Type: EXPERIMENTAL; Interventions: Device: Setting of positive end-expiratory pressure | Intervention Type: DEVICE; Name: Setting of positive end-expiratory pressure; Assigned to Arm(s): Maximal alveolar distension, Minimal alveolar distension
D: Arm Label: prone position; Type: ACTIVE_COMPARATOR; Interventions: Procedure: prone positioning | Arm Label: supine position; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: prone positioning; Assigned to Arm(s): prone position

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Two Strategies for Setting Positive End-Expiratory Pressure in Acute Lung Injury/ Acute Respiratory Distress Syndrome (ExPress Study).
Brief Summary: The aim of this multicenter randomized controlled trial is to compare the impact on mortality of patients mechanically ventilated for acute lung injury or acute respiratory distress syndrome of two strategies for setting end-expiratory pressure.


Options:
A: Arm Label: Minimal alveolar distension; Type: ACTIVE_COMPARATOR; Interventions: Device: Setting of positive end-expiratory pressure | Arm Label: Maximal alveolar distension; Type: EXPERIMENTAL; Interventions: Device: Setting of positive end-expiratory pressure | Intervention Type: DEVICE; Name: Setting of positive end-expiratory pressure; Assigned to Arm(s): Maximal alveolar distension, Minimal alveolar distension
B: Arm Label: ART Strategy; Type: EXPERIMENTAL; Interventions: Other: ART Strategy | Arm Label: ARDSNet Strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: ARDSNet Strategy | Intervention Type: OTHER; Name: ART Strategy; Assigned to Arm(s): ART Strategy | Intervention Type: OTHER; Name: ARDSNet Strategy; Assigned to Arm(s): ARDSNet Strategy
C: Arm Label: A; Type: EXPERIMENTAL; Interventions: Procedure: prone position | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: prone position; Assigned to Arm(s): A
D: Arm Label: Compliance-guided PEEP group; Type: OTHER; Interventions: Other: Positive End-expiratory Pressure (PEEP) | Arm Label: FiO2-driven-PEEP group; Type: OTHER; Interventions: Other: Positive End-expiratory Pressure (PEEP) | Intervention Type: OTHER; Name: Positive End-expiratory Pressure (PEEP); Assigned to Arm(s): Compliance-guided PEEP group, FiO2-driven-PEEP group

Answer: A